Effect of Interferon-gamma 1-b on Innate Immune Cells

Trial Profile

Effect of Interferon-gamma 1-b on Innate Immune Cells

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 22 Sep 2017

At a glance

  • Drugs Interferon gamma-1b (Primary)
  • Indications Chronic granulomatous disease
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 Sep 2017 Status changed from recruiting to active, no longer recruiting.
    • 22 Nov 2016 Status changed from not yet recruiting to recruiting.
    • 02 Jun 2016 Planned initiation date changed from 1 Dec 2015 to 1 Jul 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top